BRAND_ANALYSIS#ASTRAZENECAHEALTH & PHARMA#24 OF 26 IN HEALTH & PHARMAALIGNED
AstraZeneca
· Public · Updated 25 May 2026 11:16 UTC
#1049 of 1208 overall by tension · #24 of 26 in Health & Pharma
7Aligned
The Aligned Power
Analysis
Big pharma's best-case scenario: C=69, B=76, positive sentiment (0.40) despite sector skepticism. The 1.055 wiki_ratio normalizes what should be opaque; they've made essential-but-unsexy into institutional narrative.
IN THE NEWS (100 articles this week)
AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026 - AstraZeneca
Department of Energy Recognizes AstraZeneca for Achieving SEP 50001 at Gaithersburg Campus in Maryland - Department of Energy (.gov)
FDA approves AstraZeneca’s new kind of hypertension drug - BioPharma Dive